Over 7,500 medications in stock!
100% Original medicines of Russian and world brands
Fast international shipping and delivery!
Free shipping order $150
24/7 Customer support

No products in the cart.

MOVALIS™ solution for intramuscular injection 15mg/1.5ml (1.5ml), ampoules 5pcs

🔥 9 items sold in last 3 hours
8 people are viewing this product
Brand:
Active Ingredient:

Manufacturer:

$160.00

or
Buy from 5 to 10 items and get 2% OFF
on each product
Buy from 11 to 30 items and get 5% OFF
on each product
Buy from 31 to 100 items and get 10% OFF
on each product
Buy from 101 to ∞ items and get 15% OFF
on each product

All forms of

MOVALIS™ solution for intramuscular injection 15mg/1.5ml (1.5ml), ampoules 3pcs

$115.00
Add to cart

MOVALIS™ tablets 15mg, 10pcs

$49.00
Add to cart

Analogs of MOVALIS™

AMELOTEX™ topical gel 1% (100g), 1pc

$44.00
Add to cart

AMELOTEX™ topical gel 1% (30g), 1pc

$20.00
Add to cart

AMELOTEX™ topical gel 1% (50g), 1pc

$29.00
Add to cart

AMELOTEX™ solution for intramuscular injection 10mg/ml (1.5ml), 10pcs

$63.00
Add to cart

Table of Contents

MOVALIS™ 15mg Solution 1.5ml 5pcs Buy Online

Movalis Solution for Intramuscular Injection: A Comprehensive Overview

Experiencing debilitating pain from osteoarthritis or rheumatoid arthritis? Movalis, a nonsteroidal anti-inflammatory drug (NSAID), offers rapid relief through intramuscular injection. This comprehensive overview explores its uses, administration, benefits, and potential drawbacks.

This potent medication provides targeted pain relief, quickly addressing the inflammation and discomfort associated with various musculoskeletal conditions. Its efficacy makes it a valuable tool in managing acute pain flare-ups, offering a faster onset of action compared to oral formulations.

Movalis intramuscular injection is a convenient option for patients unable to tolerate oral medications or needing immediate pain relief. The direct delivery to the bloodstream ensures rapid absorption and swift symptom alleviation. It’s crucial to follow the prescribed dosage and administration guidelines precisely.

Understanding Movalis

Movalis, containing the active ingredient meloxicam, belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). Unlike some NSAIDs that broadly inhibit cyclooxygenase (COX) enzymes, meloxicam exhibits a more selective inhibition of COX-2. This selectivity is crucial, as COX-2 is primarily responsible for inflammation and pain production in the body, while COX-1 plays a vital role in protecting the stomach lining. This selective inhibition helps to minimize the risk of gastrointestinal side effects often associated with traditional NSAIDs.

The mechanism of action involves the reduction of prostaglandin synthesis. Prostaglandins are inflammatory mediators that contribute to pain, swelling, and fever. By inhibiting COX-2, meloxicam effectively reduces the production of these mediators, leading to a decrease in inflammation and pain. This effect is particularly beneficial in managing various musculoskeletal conditions characterized by pain and inflammation.

Movalis is available in various formulations, including oral tablets and intramuscular injections. The intramuscular injection offers a rapid route of administration, making it ideal for managing acute pain flare-ups and providing quick relief. The rapid absorption of meloxicam from the injection site leads to a faster onset of action compared to oral formulations. However, the intramuscular route is generally used for short-term pain management due to potential injection site reactions.

Importantly, Movalis is not a cure for underlying conditions like osteoarthritis or rheumatoid arthritis; rather, it effectively manages the symptoms associated with these conditions. It targets the pain and inflammation, improving mobility and quality of life for patients. Understanding this distinction is key to effective treatment and managing expectations. Always consult a healthcare professional for appropriate diagnosis and treatment.

Therapeutic Applications

Movalis intramuscular injection is primarily indicated for the short-term symptomatic treatment of acute exacerbations of painful conditions. Its rapid onset of action makes it particularly suitable for managing sudden flare-ups of pain and inflammation, providing swift relief when needed most. This targeted approach ensures that patients receive the necessary pain management without prolonged use of the medication.

Specific conditions where Movalis intramuscular injection finds therapeutic application include rheumatoid arthritis and ankylosing spondylitis (AS). In these chronic inflammatory diseases, Movalis can effectively alleviate pain and reduce inflammation during periods of heightened symptoms. The intramuscular route allows for rapid pain relief, potentially improving a patient’s mobility and quality of life during acute episodes.

Furthermore, Movalis can be considered for the management of osteoarthritis pain, especially when oral medication isn’t tolerated or immediate relief is required. However, it’s crucial to remember that Movalis only addresses the symptoms and doesn’t cure the underlying condition. Long-term management of osteoarthritis usually involves a multifaceted approach, including physical therapy and lifestyle modifications, in conjunction with appropriate medication.

While effective for pain relief, it is important to note that Movalis is not a first-line treatment for all musculoskeletal conditions. A healthcare professional will assess the individual needs of each patient and determine the most appropriate therapeutic approach. The decision to use Movalis will be based on a thorough evaluation of the patient’s condition and medical history, ensuring safe and effective treatment.

It’s crucial to emphasize the importance of adhering to prescribed dosage and duration of treatment. Inappropriate use or exceeding the recommended dosage can lead to adverse effects. Always consult with your physician before starting any new medication, including Movalis.

Dosage and Administration

The standard dosage of Movalis intramuscular injection is 15 mg administered once daily. This single daily dose is typically sufficient to provide effective pain relief and reduce inflammation. Exceeding this dosage is not recommended without explicit guidance from a healthcare professional, as it could increase the risk of adverse effects.

Administration should be performed by a healthcare professional experienced in intramuscular injections. The preferred injection site is the gluteal muscle, ensuring proper technique to minimize discomfort and potential complications. Deep intramuscular injection is crucial to optimize absorption and minimize local irritation.

The duration of treatment with Movalis intramuscular injection is typically short-term, generally limited to the acute phase of the condition. Prolonged use should be carefully considered and only undertaken under strict medical supervision. The decision to continue or discontinue treatment will be based on the patient’s response to therapy and the overall clinical picture.

Before initiating treatment, it is essential to carefully review the patient’s medical history, including any pre-existing conditions or allergies. This pre-treatment assessment helps to minimize the risk of adverse interactions or reactions. Furthermore, a healthcare professional should monitor the patient for any adverse effects during and after treatment with Movalis.

Specific instructions regarding dosage and administration may vary depending on individual patient factors and the specific clinical situation. Always follow the instructions provided by your healthcare provider meticulously. Never attempt self-administration without proper training and medical guidance.

Pros of Movalis Intramuscular Injection

One of the significant advantages of Movalis administered via intramuscular injection is its rapid onset of action. Unlike oral medications, which need to be absorbed through the gastrointestinal tract, the intramuscular route delivers meloxicam directly into the bloodstream, resulting in quicker pain relief. This rapid effect is particularly beneficial during acute pain flare-ups, providing immediate comfort when needed most.

Another key advantage is its effectiveness in managing severe pain, especially when oral medications are poorly tolerated or ineffective. Patients experiencing intense pain from conditions like rheumatoid arthritis or osteoarthritis can benefit significantly from the potent analgesic effects of Movalis delivered intramuscularly. This targeted approach can help break the cycle of pain and inflammation.

The intramuscular injection method also bypasses the potential for gastrointestinal irritation often associated with oral NSAIDs. Meloxicam, while still an NSAID, exhibits selective COX-2 inhibition, reducing the risk of stomach upset, ulcers, or other gastrointestinal complications. This feature is particularly valuable for patients with a history of gastrointestinal problems.

Furthermore, for patients experiencing difficulty swallowing or those with impaired gastrointestinal function, the intramuscular route presents a viable alternative to oral administration. This ensures that those who may not be able to take oral medication still have access to effective pain relief. The convenience of a single daily injection also improves adherence to the treatment plan.

Finally, a single intramuscular dose can provide sustained pain relief for an extended period, often lasting for a considerable portion of the day. This reduces the frequency of administration compared to other pain relief methods, improving overall patient comfort and convenience.

Cons of Movalis Intramuscular Injection

Despite its benefits, Movalis intramuscular injection, like all medications, carries potential drawbacks. One common concern is the risk of injection site reactions. These can manifest as pain, swelling, redness, or bruising at the injection site. While generally mild and transient, these reactions can cause discomfort and require careful monitoring.

Another potential disadvantage is the risk of systemic side effects, although generally less frequent than with some other NSAIDs due to meloxicam’s COX-2 selectivity. These side effects can include headache, dizziness, nausea, and gastrointestinal upset. While less common than with non-selective NSAIDs, the possibility remains and requires careful consideration, especially in patients with pre-existing conditions.

The intramuscular route of administration also necessitates professional injection, which might pose a challenge for some patients depending on their access to healthcare professionals. This lack of self-administration capability could be inconvenient for individuals living in remote areas or those with limited mobility.

Furthermore, Movalis intramuscular injection is typically intended for short-term use to manage acute pain flare-ups. Long-term use can increase the risk of various side effects, including cardiovascular events, renal impairment, and gastrointestinal complications. It’s crucial to carefully weigh the short-term benefits against the potential long-term risks.

Finally, while less frequent than with other NSAIDs, allergic reactions to meloxicam are still possible. Patients with a known allergy to meloxicam or other NSAIDs should avoid this medication. Any signs of an allergic reaction, such as rash, itching, or difficulty breathing, should be addressed immediately by a healthcare professional.

Important Considerations

Before initiating treatment with Movalis intramuscular injection, a thorough assessment of the patient’s medical history is crucial. This includes identifying any pre-existing conditions, such as heart disease, kidney disease, liver disease, or gastrointestinal problems, that could potentially be exacerbated by the medication. A comprehensive evaluation helps to minimize risks and ensure appropriate treatment.

Patients with a history of allergic reactions to NSAIDs should exercise caution and inform their healthcare provider before receiving Movalis. The potential for allergic reactions, although relatively uncommon, should be carefully considered. Patients should be aware of the signs and symptoms of allergic reactions and seek immediate medical attention if they occur.

Concurrent use of other medications needs careful consideration. Interactions with certain drugs, such as anticoagulants or diuretics, could potentially increase the risk of side effects. Therefore, a complete list of all medications, including over-the-counter drugs and herbal supplements, should be provided to the prescribing physician for thorough evaluation.

During treatment with Movalis, regular monitoring of kidney and liver function is advisable, particularly in patients with pre-existing kidney or liver impairment. This ongoing assessment helps to detect and manage potential adverse effects promptly. Close monitoring allows for timely adjustments to the treatment plan as needed.

Finally, it’s essential to emphasize the importance of adhering to the prescribed dosage and duration of treatment. Improper use or exceeding the recommended dosage can significantly increase the risk of adverse reactions. Patients should always follow the instructions provided by their healthcare provider meticulously and promptly report any unusual symptoms or side effects.

Conclusion

Movalis intramuscular injection provides a valuable option for the short-term management of acute musculoskeletal pain and inflammation. Its rapid onset of action and targeted approach make it particularly suitable for managing sudden flare-ups of symptoms in conditions like rheumatoid arthritis and osteoarthritis. However, it’s crucial to remember that Movalis only addresses symptoms, not the underlying cause.

While offering significant benefits in terms of rapid pain relief and reduced gastrointestinal side effects compared to some oral NSAIDs, potential drawbacks such as injection site reactions and systemic side effects must be considered. The decision to use Movalis should be made in consultation with a healthcare professional who can assess the individual patient’s needs and weigh the potential benefits against the risks.

The intramuscular route, while offering rapid relief, is not suitable for long-term management. Prolonged use should be carefully considered and only undertaken under strict medical supervision. Appropriate monitoring of kidney and liver function is essential, especially in patients with pre-existing conditions. Always adhere to the prescribed dosage and duration of treatment to minimize the risk of adverse effects.

Ultimately, Movalis intramuscular injection represents a powerful tool in the arsenal of pain management strategies. When used appropriately and under medical supervision, it can significantly improve patient comfort and quality of life during acute episodes of musculoskeletal pain. However, responsible use necessitates a thorough understanding of its benefits, limitations, and potential side effects.

Remember, this information is for educational purposes only and does not constitute medical advice. Always consult with a qualified healthcare professional for diagnosis and treatment of any medical condition.

  • Movalis™ Solution For Intramuscular Injection 15Mg/1.5Ml (1.5Ml), Ampoules 5Pcs Buy Online 2
    [Author]

    Georgia Austin is a seasoned SEO content writer, editor, and content marketing strategist with over 7 years of experience crafting compelling copy for leading brands in the healthcare and pharmaceutic...

    View all posts
  • Movalis™ Solution For Intramuscular Injection 15Mg/1.5Ml (1.5Ml), Ampoules 5Pcs Buy Online 4
    [Editor]

    Jonathan Brown is a seasoned professional editor, researcher, and educator with over 12 years of experience helping authors find their voice and polish their writing. As a content editor for RxPulsar....

    View all posts
  • Movalis™ Solution For Intramuscular Injection 15Mg/1.5Ml (1.5Ml), Ampoules 5Pcs Buy Online 6
    [Medical reviewer]

    Dr. Jessica Kerns is a highly accomplished pediatrician and adolescent medicine specialist who serves as a clinical instructor in the Department of Pediatrics at the Icahn School of Medicine at Mount...

    View all posts

Reviews

There are no reviews yet.

Be the first to review “MOVALIS™ solution for intramuscular injection 15mg/1.5ml (1.5ml), ampoules 5pcs”

Your email address will not be published. Required fields are marked

Similar products

VOLTAREN™ transdermal patch 30mg/day, pack 2pcs

$29.00
Add to cart

VOLTAREN™ rectal suppositories 100mg, 5pcs

$21.00
Add to cart

VOLTAREN™ rectal suppositories 50mg, 10pcs

$23.00
Add to cart

VOLTAREN™ enteric-coated tablets 25mg, 30pcs

$7.00
Add to cart

VOLTAREN™ enteric tablets 50mg, 20pcs

$7.00
Add to cart

VIPROSAL™ V topical ointment 30g, 1pc

$40.00
Add to cart

BYSTRUMGEL™ topical gel 2.5% (100g), 1pc

$41.00
Add to cart

BYSTRUMGEL™ topical gel 2.5% (30g), 1pc

$22.00
Add to cart

BYSTRUMGEL™ topical gel 2.5% (50g), 1pc

$27.00
Add to cart

AERTAL™ powder for oral suspension 100mg/3g, 20 sachets

$43.00
Add to cart

AERTAL™ tablets 100mg, 60pcs

$75.00
Add to cart

ACECLOFENAC tablets 100mg, 60pcs

$48.00
Add to cart

ACECLAGIN™ modified-release tablets 200mg, 30pcs

$92.00
Add to cart

ATORIKA™ tablets 120mg, 7pcs

$36.00
Add to cart

ATORIKA™ tablets 60mg, 14pcs

$31.00
Add to cart

ATORIKA™ tablets 90mg, 7pcs

$27.00
Add to cart

ARTROZAN™ tablets 15mg, 10pcs

$19.00
Add to cart

ARTROZILEN™ topical gel 5% (50g), 1pc

$38.00
Add to cart

ARNIGEL™ topical gel 120g, 1pc

$37.00
Add to cart

AMELOTEX™ tablets 15mg, 10pcs

$18.00
Add to cart

AMELOTEX™ solution for intramuscular injection 10mg/ml (1.5ml), 10pcs

$63.00
Add to cart

AMELOTEX™ solution for intramuscular injection 10mg/ml (1.5ml), 3pcs

$32.00
Add to cart

ALENTAL™ tablets 100mg, 20pcs

$26.00
Add to cart

ABISIL™ oily solution 20% (15ml), 1pc

$54.00
Add to cart
Select your currency